Correlation Engine 2.0
Clear Search sequence regions

  • adult (1)
  • cisplatin (3)
  • diagnosis (1)
  • humans (1)
  • man (1)
  • thymoma (5)
  • Sizes of these terms reflect their relevance to your search.

    Adaptive radiation therapy (ART) is a technique capable of reducing radiation dose to normal tissue without compromising local control. For potentially resectable thymoma, induction therapy is standard of care. Because large disease volume is common in this context, ART has been suggested to reduce toxicity from induction chemoradiation. This has not been previously illustrated in the literature. A 38-year-old man with initially unresectable thymoma was treated with induction chemoradiation including cisplatin and etoposide. He received 45 Gy in 25 fractions and ART was utilized to shrink the radiotherapy field for the final 10 fractions. Thymectomy showed Masaoka stage III disease with negative margins. He experienced no treatment-related toxicity and has no evidence of disease 8 years after diagnosis. Induction chemoradiotherapy with ART appears to be feasible, safe, and efficacious for locally advanced intact thymoma. Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.


    Neil Chevli, Ross E Bland, Andrew M Farach, Ramiro Pino, Thomas Mathews, Ekene I Okoye, Shanda Blackmon, E Brian Butler, Bin S Teh. Adaptive Radiation Therapy for Intact Thymoma: An Illustrative Report. Anticancer research. 2021 May;41(5):2467-2471

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33952472

    View Full Text